加加食品(002650.SZ):擬申請共計4億元的綜合授信額度
格隆匯2月21日丨加加食品(002650.SZ)公佈,公司第四屆董事會2020年第三次會議召開,審議通過關於《公司及子公司向銀行申請綜合授信》的議案。
會議同意公司及子公司2020年度分別向華融湘江銀行湘江新區分行申請綜合授信(疫情防控重點保障企業專項貸款)3億元,湖南三湘銀行股份有限公司申請綜合授信1億元等,共計為4億元人民幣的綜合授信額度,授信有效期1年(最終授信額度及具體起止時間以與銀行簽訂的協議約定為準),授信方式以最終與銀行簽訂的協議約定為準。授權管理層簽署相關協議及負責經辦具體程序事務。辦理過程中如涉及股東大會審議權限事項,公司將另行召開股東大會審議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.